Report Company Directory

Kronos Advanced Technologies Inc.

• Atomiq Inc., a Subsidiary of Kronos Advanced Technologies, Inc., ($KNOS) Receives USPTO Notice of Allowance for Patent Application 17/926,508 by GlobeNewsWire
• Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc. by GlobeNewsWire
• California Wildfires and Worsening Outdoor Air Quality Drive Increased Demand for Air Purifiers, Says Kronos Advanced Technologies by GlobeNewsWire
• Kronos Advanced Technologies Paid Special Cash Dividend, Reinforcing Shareholder Trust by GlobeNewsWire
• Kronos Advanced Technologies Announces Cyber Monday Savings of Up to 50% on Innovative Air Purification Products, Plus Exclusive Deals Throughout the Holiday Season by GlobeNewsWire
• Kronos Advanced Technologies Forms New Subsidiary Atomiq, Inc. to Drive Development of Advanced Nuclear Battery Technologies by GlobeNewsWire
• Kronos Advanced Technologies Forms New Subsidiary Atomiq, Inc. to Drive Development of Advanced Nuclear Battery Technologies by GlobeNewsWire
• Kronos Advanced Technologies Inc. and Yasheng Group Announce Key Milestone in Nuclear Battery Collaboration with Provisional Patent Filing by GlobeNewsWire
• Kronos Advanced Technologies, Inc. (OTC: KNOS) Announces Ex-Dividend Date for Upcoming Special Cash Dividend by GlobeNewsWire
• Kronos Advanced Technologies Declares Special Cash Dividend for Shareholders by GlobeNewsWire

Kronos Bio

• Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right by GlobeNewsWire
• Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results by GlobeNewsWire
• Kronos Bio Announces CEO Transition and Reduction in Force by GlobeNewsWire
• Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 by GlobeNewsWire
• Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives by GlobeNewsWire
• Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma by GlobeNewsWire
• Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors by GlobeNewsWire
• Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors by GlobeNewsWire
• Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease by GlobeNewsWire
• Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy by GlobeNewsWire

Kronos Inc.

Kronos Worldwide Inc.

• KRONOS WORLDWIDE, INC. REPORTS SECOND QUARTER 2025 RESULTS by GlobeNewsWire
• Kronos Worldwide, Inc. Announces Quarterly Dividend by GlobeNewsWire
• KRONOS WORLDWIDE, INC. ANNOUNCES EXPECTED SECOND QUARTER 2025 EARNINGS RELEASE DATE by GlobeNewsWire
• Kronos Worldwide, Inc. Announces Quarterly Dividend and Results of Annual Stockholder Meeting by GlobeNewsWire
• KRONOS WORLDWIDE, INC. REPORTS FIRST QUARTER 2025 RESULTS by GlobeNewsWire
• KRONOS WORLDWIDE, INC. ANNOUNCES EXPECTED FIRST QUARTER 2025 EARNINGS RELEASE DATE by GlobeNewsWire
• InsiderInsights.com Daily Ratings Report: March 12, 2025 by InsiderInsights.com
• Kronos Worldwide Inc: 2 directors by SmartInsider
• KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2024 RESULTS by GlobeNewsWire
• KRONOS WORLDWIDE, INC. ANNOUNCES QUARTERLY DIVIDEND by GlobeNewsWire

KRONOX LAB SCIENCES LIMITED